✦ LIBER ✦

HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B

✍ Scribed by Yun-Fan Liaw

Book ID: 107593835
Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 338 KB
Volume: 3
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-009-9140-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New perspectives in the treatment of HBe

New perspectives in the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B

✍ Thomas Berg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

BACKGROUND: Available treatments for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B are associated with poor sustained responses. As a result, nucleoside and nucleotide analogues are typically continued indefinitely, a strategy associated with the risk of resistance and unknown long-term

Utility of hepatitis C virus RNA determi

Utility of hepatitis C virus RNA determinations in hepatic tissue as an end point for interferon treatment of chronic hepatitis C

✍ Ahmet Gurakar; Stefano Fagiuoli; Hawazin Faruki; Nicola De Maria; Mujdat Balkan; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

A total of 41 patients with chronic hepatitis C virus (HCV) defined as abnormal liver injury test results for 6 months or more and HCV RNA positivity in plasma were studied to determine if the liver might not be the only focus of HCV infection in individuals treated with interferon alfa (IFN-a). AU

Cost-effectiveness analysis of lamivudin

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B

✍ M. BUTI; M. A. CASADO; J. L. CALLEJA; J. SALMERÓN; J. AGUILAR; M. RUEDA; R. ESTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Defects in the precore region of the HBV

Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy

✍ Kiyoshi Takeda; Yoshihiro Akahane; Hiroshi Suzuki; Hiroaki Okamoto; Fumio Tsuda; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

Hepatitis B virus DNA clones were propagated from sera of six patients with chronic hepatitis B who seroconverted from HBeAg to antibody to HBeAg either spontaneously or after administration of Q- interferon. Defects in the precore region blocking synthesis and secretion of HBeAg were detected in al

Demonstration of hepatitis B virus DNA b

Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to Anti-HBs seroconversion in patients with chronic hepatitis B

✍ Marie-Anne Loriot; Patrick Marcellin; Eric Bismuth; Michèle Martinot-Peignoux; N 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

Prediction of the response to peg-interf

Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment

✍ Bettina E. Hansen; Erik H.C.J. Buster; Ewout W. Steyerberg; Emmanuel Lesaffre; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract Peginterferon (PEG‐IFN) results in HBeAg loss combined with virologic response in only a minority of patients with HBeAg positive chronic hepatitis B. Baseline predictors of response to PEG‐IFN include HBV‐genotype, pre‐treatment HBV DNA levels, and ALT. The aims of this study were to d